LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹26 Cr | ₹51 Cr | ₹73 Cr | ₹73 Cr | ₹149 Cr |
What is the latest Total Non-Current Liabilities ratio of LYKA LABS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹51 Cr |
| Mar2023 | ₹73 Cr |
| Mar2022 | ₹73 Cr |
| Mar2021 | ₹149 Cr |
How is Total Non-Current Liabilities of LYKA LABS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | -48.85 | |
| Mar2024 | ₹51 Cr | -30.63 | |
| Mar2023 | ₹73 Cr | 0.66 | |
| Mar2022 | ₹73 Cr | -51.12 | |
| Mar2021 | ₹149 Cr | - | |
Compare Total Non-Current Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹196.5 Cr | 7.4% | -12.2% | -49.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 7.4% |
-12.2% |
-49.9% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses